Close
ACHEMA MIDDLE EAST 2026

BD Gets CE Mark for COVID-19 Application of Immune Function Assay

BD (Becton, Dickinson and Company), a leading global medical technology company, announced the CE mark and European availability of a product for assessing immune...

Lilly Announces Agreement to Acquire Disarm Therapeutics

Eli Lilly and Company announced a definitive agreement to acquire Disarm Therapeutics, a privately-held biotechnology company creating a new class of disease-modifying therapeutics for...

COVID-19 Long-Acting AntiBody (LAAB) combination AZD7442 rapidly advances into Phase III clinical trials

AstraZeneca’s long-acting antibody (LAAB) combination, AZD7442, will advance into two Phase III clinical trials in more than 6,000 participants at sites in and outside...

CPhI Announces 17th Annual CPhI Pharma Awards Winners

The winners of the 17th annual CPhI Pharma Awards, Powered by Informa Pharma Intelligence, were announced at its first-ever virtual ceremony on 13 October...

Frankfurt Cargo Services achieves IATA CEIV pharma certification

Cargo handler FCS Frankfurt Cargo Services has successfully concluded the IATA CEIV certification process for its pharma operations. The handler said it had upgraded its...

Worldwide Flight Services prepares for Covid-19 vaccine with Project Coldstream

Cargo handler Worldwide Flight Services (WFS) has launched Project Coldstream to co-ordinate its response to the anticipated global transportation of some 16bn doses of...

Amgen, Cytokinetics And Servier Announce Topline Results From GALACTIC-HF, In Patients With Heart Failure

Amgen, Cytokinetics, Incorporated and Servier announced topline results from GALACTIC-HF, a Phase 3 pivotal clinical trial of omecamtiv mecarbil in patients with heart failure...

Subscribe Our Newsletter

White Papers

The Future of Digital Health

The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....

Five Best Practices to Deliver Exceptional Multichannel Experiences

A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...

The Impact and Use of Social Media in Pharmacovigilance

Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...